NNVC — NanoViricides Income Statement
0.000.00%
Last trade - 00:00
- $12.96m
- $7.71m
- 24
- 37
- 28
- 20
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8.66 | 8 | 8.74 | 8.11 | 8.94 |
Operating Profit | -8.66 | -8 | -8.74 | -8.11 | -8.94 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -8.42 | -13.4 | -8.82 | -8.11 | -8.59 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.42 | -13.4 | -8.82 | -8.11 | -8.59 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.42 | -13.4 | -8.82 | -8.11 | -8.59 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.42 | -13.4 | -8.82 | -8.11 | -8.59 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.35 | -2.39 | -0.809 | -0.703 | -0.739 |